Sevdenur Akçay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sevdenur Akçay has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Güven Akçay
Department of Biophysics, Faculty of Medicine, Bolu Abant İzzet Baysal University, 14030 Bolu, Turkey
9 shared publications - Ali Osman Arslan
Department of Medical Biology, Faculty of Medicine, Bolu Abant Izzet Baysal University, 14030 Bolu, Turkey
6 shared publications - Ahmet Hacimuftuoglu
Department of Medical Pharmacology, Faculty of Medicine, Ataturk University, Erzurum 25240, Turkey
1 shared publication - Aydın Him
Department of Physiology, Faculty of Medicine, Bolu Abant Izzet Baysal University, Bolu, Turkey
1 shared publication - Dana Zaqzouq
Department of Physiology, Faculty of Medicine, Bolu Abant Izzet Baysal University, Bolu, Turkey
1 shared publication - Fatma Yesilyurt
Atatürk Universitesi
1 shared publication
Latest Publications
- 2 October 2026
- Published by Springer Nature in Neurophysiology
- p. 1-17
Advanced machine learning-based differentiation of acute ischemic and hemorrhagic stroke
- 2 October 2026
- Published by Springer Nature in Neurophysiology
- p. 1-17
Advanced machine learning-based differentiation of acute ischemic and hemorrhagic stroke
- Open Access
- 1 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (10) , 1428
Anodal Transcranial Direct Current Stimulation Reduces Neuroinflammation and Cholinergic Dysregulation After Young Adult Traumatic Brain Injury
Traumatic brain injury (TBI) during childhood and adolescence can result in persistent motor and cognitive dysfunction due to secondary injury cascades involving neuroinflammation and disruption of neurotransmitter homeostasis. Although transcranial Direct Current Stimulation (tDCS) is a promising non-invasive neuromodulatory intervention, its effects on neuroinflammatory and cholinergic responses following young adult TBI remain incompletely understood. We investigated the effects of anodal and cathodal tDCS on functional outcomes, neuroinflammatory responses, and cholinergic regulatory markers following experimental young adult TBI. Two-month-old male Wistar rats underwent diffuse TBI using the Marmarou weight-drop model and were assigned to Sham, TBI, TBI + anodal tDCS, or TBI + cathodal tDCS groups. tDCS (1 mA, 30 min/day) was initiated 2 h post-injury and applied for 7 consecutive days. Functional outcomes were evaluated using the Open Field, Novel Object Recognition, and Y-maze tests. Neuroinflammatory responses were assessed by measuring tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) levels in the hippocampus and motor cortex using ELISA. Cholinergic regulatory changes were evaluated by analyzing acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) protein expression using Western blotting. Young adult TBI induced significant locomotor and cognitive deficits, accompanied by increased TNF-α and IL-1β levels and alterations in AChE and ChAT expression in the hippocampus and motor cortex. Anodal tDCS significantly improved locomotor activity, recognition memory, and spatial working memory, while attenuating trauma-associated elevations in pro-inflammatory cytokines and reducing TBI-associated alterations in cholinergic regulatory markers. In contrast, cathodal tDCS produced limited behavioral and molecular effects. The effects of anodal stimulation were observed across both the hippocampus and motor cortex, suggesting coordinated modulation of neuroinflammatory and cholinergic responses. Collectively, these findings indicate that early anodal tDCS is associated with improved functional outcomes and modulation of neuroinflammatory and cholinergic responses following young adult TBI. These results support further investigation of anodal tDCS as a potential neuromodulatory approach for promoting recovery after TBI.
- 1 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (10) , 1428
Open AccessAnodal Transcranial Direct Current Stimulation Reduces Neuroinflammation and Cholinergic Dysregulation After Young Adult Traumatic Brain Injury
Traumatic brain injury (TBI) during childhood and adolescence can result in persistent motor and cognitive dysfunction due to secondary injury cascades involving neuroinflammation and disruption of neurotransmitter homeostasis. Although transcranial Direct Current Stimulation (tDCS) is a promising non-invasive neuromodulatory intervention, its effects on neuroinflammatory and cholinergic responses following young adult TBI remain incompletely understood. We investigated the effects of anodal and cathodal tDCS on functional outcomes, neuroinflammatory responses, and cholinergic regulatory markers following experimental young adult TBI. Two-month-old male Wistar rats underwent diffuse TBI using the Marmarou weight-drop model and were assigned to Sham, TBI, TBI + anodal tDCS, or TBI + cathodal tDCS groups. tDCS (1 mA, 30 min/day) was initiated 2 h post-injury and applied for 7 consecutive days. Functional outcomes were evaluated using the Open Field, Novel Object Recognition, and Y-maze tests. Neuroinflammatory responses were assessed by measuring tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) levels in the hippocampus and motor cortex using ELISA. Cholinergic regulatory changes were evaluated by analyzing acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) protein expression using Western blotting. Young adult TBI induced significant locomotor and cognitive deficits, accompanied by increased TNF-α and IL-1β levels and alterations in AChE and ChAT expression in the hippocampus and motor cortex. Anodal tDCS significantly improved locomotor activity, recognition memory, and spatial working memory, while attenuating trauma-associated elevations in pro-inflammatory cytokines and reducing TBI-associated alterations in cholinergic regulatory markers. In contrast, cathodal tDCS produced limited behavioral and molecular effects. The effects of anodal stimulation were observed across both the hippocampus and motor cortex, suggesting coordinated modulation of neuroinflammatory and cholinergic responses. Collectively, these findings indicate that early anodal tDCS is associated with improved functional outcomes and modulation of neuroinflammatory and cholinergic responses following young adult TBI. These results support further investigation of anodal tDCS as a potential neuromodulatory approach for promoting recovery after TBI.
- Open Access
- 8 September 2026
- Published by Springer Nature in Discover Neuroscience
- Vol. 21 (1) , 97
Experimental epilepsy models for mechanistic investigation and translational research
Epilepsy is not merely a chronic neurological disorder characterized by recurrent, spontaneous seizures at the clinical level; rather, it represents a complex pathophysiological condition involving profound structural, functional, and molecular reorganization within neuronal networks. The marked heterogeneity of epilepsy arises from the multilayered interplay of genetic susceptibility, acquired brain insults such as trauma, ischemia, or infection, developmental abnormalities, and environmental factors. This multifactorial etiology poses substantial challenges for clinical management and limits the effectiveness of current therapeutic approaches, which are largely restricted to symptomatic seizure suppression. Experimental epilepsy models constitute indispensable tools for addressing these unmet clinical and scientific needs. Chemical, electrical, genetic, and acquired models enable systematic investigation of epilepsy across multiple biological scales, ranging from alterations in neuronal excitability and synaptic plasticity to neuroinflammatory processes and network-level synchronization disturbances. Beyond providing mechanistic insight, these models serve as essential platforms for preclinical evaluation of novel pharmacological agents and neuromodulation-based therapeutic strategies. The review encompasses a broad experimental spectrum, including chemoconvulsant models such as pentylenetetrazol, pilocarpine, and kainic acid; electrical stimulation paradigms; genetic and developmental models; and acquired epilepsy models. In addition, in vitro and ex vivo systems, outcome measures, and model optimization strategies for drug screening and therapeutic development are discussed. By highlighting the limitations of single-model approaches and emphasizing complementary experimental strategies, this review aims to advance a comprehensive understanding of epilepsy pathophysiology and support the development of more effective, mechanism-based therapies.
- 8 September 2026
- Published by Springer Nature in Discover Neuroscience
- Vol. 21 (1) , 97
Open AccessExperimental epilepsy models for mechanistic investigation and translational research
Epilepsy is not merely a chronic neurological disorder characterized by recurrent, spontaneous seizures at the clinical level; rather, it represents a complex pathophysiological condition involving profound structural, functional, and molecular reorganization within neuronal networks. The marked heterogeneity of epilepsy arises from the multilayered interplay of genetic susceptibility, acquired brain insults such as trauma, ischemia, or infection, developmental abnormalities, and environmental factors. This multifactorial etiology poses substantial challenges for clinical management and limits the effectiveness of current therapeutic approaches, which are largely restricted to symptomatic seizure suppression. Experimental epilepsy models constitute indispensable tools for addressing these unmet clinical and scientific needs. Chemical, electrical, genetic, and acquired models enable systematic investigation of epilepsy across multiple biological scales, ranging from alterations in neuronal excitability and synaptic plasticity to neuroinflammatory processes and network-level synchronization disturbances. Beyond providing mechanistic insight, these models serve as essential platforms for preclinical evaluation of novel pharmacological agents and neuromodulation-based therapeutic strategies. The review encompasses a broad experimental spectrum, including chemoconvulsant models such as pentylenetetrazol, pilocarpine, and kainic acid; electrical stimulation paradigms; genetic and developmental models; and acquired epilepsy models. In addition, in vitro and ex vivo systems, outcome measures, and model optimization strategies for drug screening and therapeutic development are discussed. By highlighting the limitations of single-model approaches and emphasizing complementary experimental strategies, this review aims to advance a comprehensive understanding of epilepsy pathophysiology and support the development of more effective, mechanism-based therapies.
- Open Access
- 23 June 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 660
Protective Effects of Gallic Acid on Oxidative and Inflammatory Markers in the Hippocampus and Prefrontal Cortex of a Ketamine-Induced Schizophrenia-like Model
Background: Schizophrenia is a chronic neuropsychiatric disorder characterized by cognitive impairment, behavioral abnormalities, neuroinflammation, and oxidative stress. Increasing evidence suggests that dysregulated inflammatory cytokines and impaired antioxidant defenses contribute to schizophrenia pathophysiology. This study investigated the neuroprotective and anti-inflammatory effects of Gallic Acid (GA) in a ketamine-induced experimental schizophrenia model. Methods: Thirty male Balb/C mice were randomly divided into control, ketamine, and ketamine + GA groups. Schizophrenia was induced with ketamine (25 mg/kg/day) for 7 days, while the treatment group additionally received GA (60 mg/kg/day) for another 7 days. Behavioral tests, including open field, novel object recognition, and tail suspension tests, were performed to evaluate locomotor activity, cognition, and depressive-like behavior. Tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-18 (IL-18), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), total antioxidant status (TAS), and total oxidant status (TOS) levels were analyzed in hippocampal and prefrontal cortex tissues to assess inflammatory and oxidative stress-related alterations. Results: Ketamine induced schizophrenia-like behaviors, including hyperlocomotion, memory impairment, and increased immobility. These behavioral alterations were accompanied by significantly elevated TNF-α, IL-1β, IL-18, and TOS levels, alongside reduced SOD, CAT, GSH-Px, and TAS levels in the hippocampus and prefrontal cortex. GA treatment ameliorated behavioral impairments, restored antioxidant enzymes, increased TAS levels, and reduced pro-inflammatory cytokines and TOS in these brain regions. Conclusions: GA exerted neuroprotective effects in the ketamine-induced schizophrenia model by reducing oxidative stress, neuroinflammation, and behavioral deficits. These findings suggest that Gallic Acid may serve as a promising therapeutic candidate for schizophrenia through modulation of inflammatory and oxidative stress pathways.
- 23 June 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 660
Open AccessProtective Effects of Gallic Acid on Oxidative and Inflammatory Markers in the Hippocampus and Prefrontal Cortex of a Ketamine-Induced Schizophrenia-like Model
Background: Schizophrenia is a chronic neuropsychiatric disorder characterized by cognitive impairment, behavioral abnormalities, neuroinflammation, and oxidative stress. Increasing evidence suggests that dysregulated inflammatory cytokines and impaired antioxidant defenses contribute to schizophrenia pathophysiology. This study investigated the neuroprotective and anti-inflammatory effects of Gallic Acid (GA) in a ketamine-induced experimental schizophrenia model. Methods: Thirty male Balb/C mice were randomly divided into control, ketamine, and ketamine + GA groups. Schizophrenia was induced with ketamine (25 mg/kg/day) for 7 days, while the treatment group additionally received GA (60 mg/kg/day) for another 7 days. Behavioral tests, including open field, novel object recognition, and tail suspension tests, were performed to evaluate locomotor activity, cognition, and depressive-like behavior. Tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-18 (IL-18), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), total antioxidant status (TAS), and total oxidant status (TOS) levels were analyzed in hippocampal and prefrontal cortex tissues to assess inflammatory and oxidative stress-related alterations. Results: Ketamine induced schizophrenia-like behaviors, including hyperlocomotion, memory impairment, and increased immobility. These behavioral alterations were accompanied by significantly elevated TNF-α, IL-1β, IL-18, and TOS levels, alongside reduced SOD, CAT, GSH-Px, and TAS levels in the hippocampus and prefrontal cortex. GA treatment ameliorated behavioral impairments, restored antioxidant enzymes, increased TAS levels, and reduced pro-inflammatory cytokines and TOS in these brain regions. Conclusions: GA exerted neuroprotective effects in the ketamine-induced schizophrenia model by reducing oxidative stress, neuroinflammation, and behavioral deficits. These findings suggest that Gallic Acid may serve as a promising therapeutic candidate for schizophrenia through modulation of inflammatory and oxidative stress pathways.
- 28 April 2026
- Published by Istanbul University in Experimed
- Vol. 16 (1) , 1-6
Anti-Cancer Effects of Neocuproine via Copper Chelation in A549 Lung Adenocarcinoma Cells
Objective: Neocuproine, a dipyridyl derivative with high affinity for copper ions, was investigated for its effects on human lung adenocarcinoma A549 cells, a key model for lung cancer research. Copper ions play crucial roles in cellular functions, such as angiogenesis and oxidative stress regulation, and their dysregulation is linked to tumor progression. This study evaluated neocuproine’s capacity to inhibit A549 cell proliferation and induce apoptosis, with a focus on pro-inflammatory cytokines and oxidative stress markers.Materials and Methods: To assess the cytotoxic effects of neocuproine, A549 cells were treated with doses ranging from 0.1 to 1000 μM. After 24 hours of incubation, cell viability was assessed using the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Additionally, total antioxidant status (TAS), total oxidant status (TOS), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) levels were quantified using enzyme-linked immunosorbent assay (ELISA).Results: A reduction in cell viability was observed in a concentration-dependent manner, with notable cytotoxic effects particularly evident at 10 and 100 μM doses. The IC50 of neocuproine was calculated as 31.28 μM (p<0.001). Changes in TAS, TOS, IL-6, and TNF-α levels corroborated the cytotoxicity findings from the MTT assay.Conclusion: Neocuproine effectively inhibited the growth of A549 lung cancer cells. This cytotoxic effect was particularly pronounced at doses between 10 and 100 µM, and was mediated by increasing oxidative stress and modulating inflammatory responses. These findings suggest that neocuproine is a potential therapeutic candidate for lung cancer. Further research is needed to fully understand its effects on healthy cells and biological systems.
- 28 April 2026
- Published by Istanbul University in Experimed
- Vol. 16 (1) , 1-6
Anti-Cancer Effects of Neocuproine via Copper Chelation in A549 Lung Adenocarcinoma Cells
Objective: Neocuproine, a dipyridyl derivative with high affinity for copper ions, was investigated for its effects on human lung adenocarcinoma A549 cells, a key model for lung cancer research. Copper ions play crucial roles in cellular functions, such as angiogenesis and oxidative stress regulation, and their dysregulation is linked to tumor progression. This study evaluated neocuproine’s capacity to inhibit A549 cell proliferation and induce apoptosis, with a focus on pro-inflammatory cytokines and oxidative stress markers.Materials and Methods: To assess the cytotoxic effects of neocuproine, A549 cells were treated with doses ranging from 0.1 to 1000 μM. After 24 hours of incubation, cell viability was assessed using the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Additionally, total antioxidant status (TAS), total oxidant status (TOS), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) levels were quantified using enzyme-linked immunosorbent assay (ELISA).Results: A reduction in cell viability was observed in a concentration-dependent manner, with notable cytotoxic effects particularly evident at 10 and 100 μM doses. The IC50 of neocuproine was calculated as 31.28 μM (p<0.001). Changes in TAS, TOS, IL-6, and TNF-α levels corroborated the cytotoxicity findings from the MTT assay.Conclusion: Neocuproine effectively inhibited the growth of A549 lung cancer cells. This cytotoxic effect was particularly pronounced at doses between 10 and 100 µM, and was mediated by increasing oxidative stress and modulating inflammatory responses. These findings suggest that neocuproine is a potential therapeutic candidate for lung cancer. Further research is needed to fully understand its effects on healthy cells and biological systems.
- 3 April 2026
- Published by Academician Publishing
- p. 193-206
Deneysel Şizofreni Modelleri
Şizofreni, dünya genelinde milyonlarca insanı etkileyen ve karmaşık etiyolojisi nedeniyle araştırılması güç olan ciddi bir nöropsikiyatrik bozukluktur. Hastalığın genetik, çevresel ve nörogelişimsel faktörlerin etkileşimiyle ortaya çıkması, patofizyolojik mekanizmaların çözülmesini zorlaştırmakta ve biyolojik belirteç eksikliği tanıyı güçleştirmektedir. Bu nedenle deneysel hayvan modelleri, şizofreninin altında yatan nörobiyolojik süreçlerin anlaşılması ve yeni tedavi yaklaşımlarının geliştirilmesi için kritik bir araç haline gelmiştir. Ancak insan zihnine özgü bilişsel ve duygusal süreçlerin tam olarak modellenememesi önemli bir sınırlılık oluşturmaktadır. Güncel araştırmalar, prefrontal korteks ve hipokampus gibi temel beyin bölgelerindeki işlevsel bozuklukların hayvanlarda çeşitli yöntemlerle taklit edilmesi üzerine yoğunlaşmaktadır. Şizofreni modellemesinde üç temel yaklaşım öne çıkmaktadır: transgenik, farmakolojik ve nörogelişimsel modeller. Bu bölümde, söz konusu modellerin kuramsal temelleri, deneysel uygulamaları, translasyonel geçerliliği ve her birinin avantaj ile sınırlılıkları bütüncül bir bakış açısıyla ele alınmaktadır. Amaç, araştırmacılara şizofreni patofizyolojisini anlamada ve terapötik stratejiler geliştirmede kullanılabilecek kapsamlı, metodolojik bir rehber sunmaktır. Schizophrenia is a severe neuropsychiatric disorder affecting millions worldwide, characterized by complex interactions of genetic, environmental, and neurodevelopmental factors. The absence of definitive biological markers and the multifaceted nature of its symptoms make both diagnosis and mechanistic investigation challenging. Consequently, experimental animal models have become indispensable tools for exploring the underlying neurobiological pathways of the disorder and for developing novel therapeutic strategies. Despite inherent limitations—particularly the difficulty of replicating human-specific cognitive and emotional processes—recent advances have enabled the modeling of dysfunctions in key brain regions such as the prefrontal cortex and hippocampus. Current experimental approaches fall into three major categories: transgenic, pharmacological, and neurodevelopmental models. Each provides unique strengths and constraints depending on the aspect of pathology being examined. This chapter presents an integrated overview of these experimental models, detailing their theoretical rationale, methodological applications, translational relevance, and practical limitations. The aim is to offer researchers a concise yet comprehensive guide to selecting and implementing appropriate animal models for advancing our understanding of schizophrenia pathophysiology and supporting the development of effective treatments.
- 3 April 2026
- Published by Academician Publishing
- p. 193-206
Deneysel Şizofreni Modelleri
Şizofreni, dünya genelinde milyonlarca insanı etkileyen ve karmaşık etiyolojisi nedeniyle araştırılması güç olan ciddi bir nöropsikiyatrik bozukluktur. Hastalığın genetik, çevresel ve nörogelişimsel faktörlerin etkileşimiyle ortaya çıkması, patofizyolojik mekanizmaların çözülmesini zorlaştırmakta ve biyolojik belirteç eksikliği tanıyı güçleştirmektedir. Bu nedenle deneysel hayvan modelleri, şizofreninin altında yatan nörobiyolojik süreçlerin anlaşılması ve yeni tedavi yaklaşımlarının geliştirilmesi için kritik bir araç haline gelmiştir. Ancak insan zihnine özgü bilişsel ve duygusal süreçlerin tam olarak modellenememesi önemli bir sınırlılık oluşturmaktadır. Güncel araştırmalar, prefrontal korteks ve hipokampus gibi temel beyin bölgelerindeki işlevsel bozuklukların hayvanlarda çeşitli yöntemlerle taklit edilmesi üzerine yoğunlaşmaktadır. Şizofreni modellemesinde üç temel yaklaşım öne çıkmaktadır: transgenik, farmakolojik ve nörogelişimsel modeller. Bu bölümde, söz konusu modellerin kuramsal temelleri, deneysel uygulamaları, translasyonel geçerliliği ve her birinin avantaj ile sınırlılıkları bütüncül bir bakış açısıyla ele alınmaktadır. Amaç, araştırmacılara şizofreni patofizyolojisini anlamada ve terapötik stratejiler geliştirmede kullanılabilecek kapsamlı, metodolojik bir rehber sunmaktır. Schizophrenia is a severe neuropsychiatric disorder affecting millions worldwide, characterized by complex interactions of genetic, environmental, and neurodevelopmental factors. The absence of definitive biological markers and the multifaceted nature of its symptoms make both diagnosis and mechanistic investigation challenging. Consequently, experimental animal models have become indispensable tools for exploring the underlying neurobiological pathways of the disorder and for developing novel therapeutic strategies. Despite inherent limitations—particularly the difficulty of replicating human-specific cognitive and emotional processes—recent advances have enabled the modeling of dysfunctions in key brain regions such as the prefrontal cortex and hippocampus. Current experimental approaches fall into three major categories: transgenic, pharmacological, and neurodevelopmental models. Each provides unique strengths and constraints depending on the aspect of pathology being examined. This chapter presents an integrated overview of these experimental models, detailing their theoretical rationale, methodological applications, translational relevance, and practical limitations. The aim is to offer researchers a concise yet comprehensive guide to selecting and implementing appropriate animal models for advancing our understanding of schizophrenia pathophysiology and supporting the development of effective treatments.
- 3 April 2026
- Published by Academician Publishing
- p. 287-314
Moleküler Analiz Yöntemleri: PCR, RT-qPCR, ELISA, Western Blot ve Protein Düzeyi Ölçümü
Moleküler ve immünokimyasal analiz yöntemleri, biyolojik sistemlerde genetik bilginin ifade edilmesi ve bunun protein düzeyindeki fonksiyonel karşılığının ortaya konulmasında temel bir rol üstlenmektedir. Bu bölümde, biyomedikal araştırmalarda yaygın olarak kullanılan ELISA, PCR, RT-qPCR, Western Blot ve protein düzeyi ölçüm yöntemleri; temel çalışma prensipleri, uygulama alanları ve analitik güçlü yönleriyle birlikte bütüncül bir çerçevede ele alınmaktadır. ELISA, özgül antijen-antikor etkileşimlerine dayalı yapısı sayesinde sitokinler, hormonlar, büyüme faktörleri ve antikorlar gibi çok sayıda biyomolekülün kantitatif veya yarı-kantitatif ölçümüne olanak tanır ve klinik ile preklinik çalışmalar arasında önemli bir köprü oluşturur. PCR ve RT-qPCR teknikleri, özgül DNA dizilerinin çoğaltılması ve RNA moleküllerinden gen ekspresyonunun gerçek zamanlı olarak kantitatif değerlendirilmesi yoluyla, hücresel düzeydeki transkripsiyonel değişimlerin yüksek duyarlılıkla analiz edilmesini sağlar. Floresan tabanlı tespit sistemleri, Ct değerine dayalı kantifikasyon yaklaşımları ve uygun referans genlerle yapılan normalizasyon stratejileri, RT-qPCR verilerinin doğruluğu ve biyolojik anlamlılığı açısından kritik öneme sahiptir. Protein analizinde temel yöntemlerden biri olan Western Blot, proteinlerin moleküler ağırlıklarına göre ayrılması ve özgül antikorlar aracılığıyla tespit edilmesi sayesinde protein ekspresyon düzeyleri, izoformlar ve post-translasyonel modifikasyonlar hakkında ayrıntılı bilgi sunar. Bununla birlikte Bradford, Lowry ve BCA gibi toplam protein kantifikasyon yöntemleri, örneklerin standardizasyonu ve deneysel karşılaştırmalar için vazgeçilmezdir. Bu yöntemlerin birlikte ve tamamlayıcı şekilde kullanılması, gen ekspresyonu ile protein düzeyi arasındaki ilişkinin bütüncül olarak değerlendirilmesine olanak tanır. Güvenilir ve tekrarlanabilir sonuçlar elde edebilmek için uygun örnek hazırlığı, deneysel kontroller, analitik validasyon adımları ve istatistiksel değerlendirmelerin titizlikle planlanması gerekmektedir. Sonuç olarak, bu bölümde ele alınan analiz yaklaşımları, biyolojik süreçlerin moleküler temellerinin aydınlatılması ve hastalık mekanizmalarının anlaşılmasında güçlü ve vazgeçilmez araçlar sunmaktadır. Molecular and immunochemical analysis methods play a fundamental role in elucidating the expression of genetic information and its functional counterparts at the protein level in biological systems. This section presents a comprehensive overview of ELISA, PCR, RT-qPCR, Western blot, and protein quantification methods that are widely used in biomedical research, addressing their basic principles of operation, application areas, and analytical strengths within an integrated framework. ELISA enables the quantitative or semi-quantitative measurement of a wide range of biomolecules, including cytokines, hormones, growth factors, and antibodies, through its structure based on specific antigen–antibody interactions, thereby serving as an important bridge between clinical and preclinical studies. PCR and RT-qPCR techniques allow highly sensitive analysis of transcriptional changes at the cellular level by enabling the amplification of specific DNA sequences and the real-time quantitative evaluation of gene expression from RNA molecules. Fluorescence-based detection systems, Ct value–based quantification approaches, and normalization strategies employing appropriate reference genes are critical for ensuring the accuracy and biological relevance of RT-qPCR data. Western blot, one of the fundamental methods in protein analysis, provides detailed information on protein expression levels, isoforms, and post-translational modifications by separating proteins according to their molecular weight and detecting them through specific antibodies. In addition, total protein quantification methods such as the Bradford, Lowry, and BCA assays are indispensable for sample standardization and comparative experimental analyses. The combined and complementary use of these methods allows a holistic evaluation of the relationship between gene expression and protein levels. To obtain reliable and reproducible results, careful planning of sample preparation, experimental controls, analytical validation steps, and statistical evaluations is essential. In conclusion, the analytical approaches discussed in this section represent powerful and indispensable tools for elucidating the molecular foundations of biological processes and for understanding disease mechanisms.
- 3 April 2026
- Published by Academician Publishing
- p. 287-314
Moleküler Analiz Yöntemleri: PCR, RT-qPCR, ELISA, Western Blot ve Protein Düzeyi Ölçümü
Moleküler ve immünokimyasal analiz yöntemleri, biyolojik sistemlerde genetik bilginin ifade edilmesi ve bunun protein düzeyindeki fonksiyonel karşılığının ortaya konulmasında temel bir rol üstlenmektedir. Bu bölümde, biyomedikal araştırmalarda yaygın olarak kullanılan ELISA, PCR, RT-qPCR, Western Blot ve protein düzeyi ölçüm yöntemleri; temel çalışma prensipleri, uygulama alanları ve analitik güçlü yönleriyle birlikte bütüncül bir çerçevede ele alınmaktadır. ELISA, özgül antijen-antikor etkileşimlerine dayalı yapısı sayesinde sitokinler, hormonlar, büyüme faktörleri ve antikorlar gibi çok sayıda biyomolekülün kantitatif veya yarı-kantitatif ölçümüne olanak tanır ve klinik ile preklinik çalışmalar arasında önemli bir köprü oluşturur. PCR ve RT-qPCR teknikleri, özgül DNA dizilerinin çoğaltılması ve RNA moleküllerinden gen ekspresyonunun gerçek zamanlı olarak kantitatif değerlendirilmesi yoluyla, hücresel düzeydeki transkripsiyonel değişimlerin yüksek duyarlılıkla analiz edilmesini sağlar. Floresan tabanlı tespit sistemleri, Ct değerine dayalı kantifikasyon yaklaşımları ve uygun referans genlerle yapılan normalizasyon stratejileri, RT-qPCR verilerinin doğruluğu ve biyolojik anlamlılığı açısından kritik öneme sahiptir. Protein analizinde temel yöntemlerden biri olan Western Blot, proteinlerin moleküler ağırlıklarına göre ayrılması ve özgül antikorlar aracılığıyla tespit edilmesi sayesinde protein ekspresyon düzeyleri, izoformlar ve post-translasyonel modifikasyonlar hakkında ayrıntılı bilgi sunar. Bununla birlikte Bradford, Lowry ve BCA gibi toplam protein kantifikasyon yöntemleri, örneklerin standardizasyonu ve deneysel karşılaştırmalar için vazgeçilmezdir. Bu yöntemlerin birlikte ve tamamlayıcı şekilde kullanılması, gen ekspresyonu ile protein düzeyi arasındaki ilişkinin bütüncül olarak değerlendirilmesine olanak tanır. Güvenilir ve tekrarlanabilir sonuçlar elde edebilmek için uygun örnek hazırlığı, deneysel kontroller, analitik validasyon adımları ve istatistiksel değerlendirmelerin titizlikle planlanması gerekmektedir. Sonuç olarak, bu bölümde ele alınan analiz yaklaşımları, biyolojik süreçlerin moleküler temellerinin aydınlatılması ve hastalık mekanizmalarının anlaşılmasında güçlü ve vazgeçilmez araçlar sunmaktadır. Molecular and immunochemical analysis methods play a fundamental role in elucidating the expression of genetic information and its functional counterparts at the protein level in biological systems. This section presents a comprehensive overview of ELISA, PCR, RT-qPCR, Western blot, and protein quantification methods that are widely used in biomedical research, addressing their basic principles of operation, application areas, and analytical strengths within an integrated framework. ELISA enables the quantitative or semi-quantitative measurement of a wide range of biomolecules, including cytokines, hormones, growth factors, and antibodies, through its structure based on specific antigen–antibody interactions, thereby serving as an important bridge between clinical and preclinical studies. PCR and RT-qPCR techniques allow highly sensitive analysis of transcriptional changes at the cellular level by enabling the amplification of specific DNA sequences and the real-time quantitative evaluation of gene expression from RNA molecules. Fluorescence-based detection systems, Ct value–based quantification approaches, and normalization strategies employing appropriate reference genes are critical for ensuring the accuracy and biological relevance of RT-qPCR data. Western blot, one of the fundamental methods in protein analysis, provides detailed information on protein expression levels, isoforms, and post-translational modifications by separating proteins according to their molecular weight and detecting them through specific antibodies. In addition, total protein quantification methods such as the Bradford, Lowry, and BCA assays are indispensable for sample standardization and comparative experimental analyses. The combined and complementary use of these methods allows a holistic evaluation of the relationship between gene expression and protein levels. To obtain reliable and reproducible results, careful planning of sample preparation, experimental controls, analytical validation steps, and statistical evaluations is essential. In conclusion, the analytical approaches discussed in this section represent powerful and indispensable tools for elucidating the molecular foundations of biological processes and for understanding disease mechanisms.
- 3 April 2026
- Published by Academician Publishing
- p. 183-192
Deneysel Migren Modelleri
Migren, trigeminovasküler sistem, nörojenik inflamasyon ve santral duyarlılaşma gibi karmaşık mekanizmalarla ortaya çıkan, yaşam kalitesini ciddi şekilde etkileyen nörolojik bir hastalıktır. Bu mekanizmaları aydınlatmak ve yeni tedaviler geliştirmek için araştırmacılar, farklı yönleri taklit eden çok çeşitli deneysel hayvan modelleri kullanır. Bu bölümde, nitrogliserin veya CGRP uygulaması gibi tetikleyici modellerden, kortikal yayılan depolarizasyon ve genetik modellere kadar geniş bir yelpaze tanıtılmıştır. Her modelin, örneğin vasküler değişiklikleri, ağrı davranışını veya kronikleşme sürecini araştırmada kendine özgü güçlü yanları bulunmaktadır. Ancak, tür farklılıkları ve modelin klinik durumu ne ölçüde yansıttığı gibi sınırlamalar da dikkate alınmalıdır. Sonuç olarak, doğru soruyu sormak ve uygun modeli seçmek, migren gizeminin çözülmesindeki en kritik adımlardan biridir. Migraine is a debilitating neurological disorder characterized by complex mechanisms involving the trigeminovascular system, neurogenic inflammation, and central sensitization. To decipher these mechanisms and develop novel therapies, researchers employ a wide array of experimental animal models, each mimicking distinct facets of the disease. This chapter reviews this spectrum, ranging from provocative models using nitroglycerin or CGRP administration to models of cortical spreading depression (CSD) and genetic (FHM) susceptibility. Each model offers unique strengths for investigating specific aspects, such as vascular changes, pain-related behaviour, or chronification processes. However, their limitations, including species differences and translational validity, must be carefully considered. Ultimately, asking the right question and selecting the appropriate model remain pivotal steps in unraveling the enigma of migraine.
- 3 April 2026
- Published by Academician Publishing
- p. 183-192
Deneysel Migren Modelleri
Migren, trigeminovasküler sistem, nörojenik inflamasyon ve santral duyarlılaşma gibi karmaşık mekanizmalarla ortaya çıkan, yaşam kalitesini ciddi şekilde etkileyen nörolojik bir hastalıktır. Bu mekanizmaları aydınlatmak ve yeni tedaviler geliştirmek için araştırmacılar, farklı yönleri taklit eden çok çeşitli deneysel hayvan modelleri kullanır. Bu bölümde, nitrogliserin veya CGRP uygulaması gibi tetikleyici modellerden, kortikal yayılan depolarizasyon ve genetik modellere kadar geniş bir yelpaze tanıtılmıştır. Her modelin, örneğin vasküler değişiklikleri, ağrı davranışını veya kronikleşme sürecini araştırmada kendine özgü güçlü yanları bulunmaktadır. Ancak, tür farklılıkları ve modelin klinik durumu ne ölçüde yansıttığı gibi sınırlamalar da dikkate alınmalıdır. Sonuç olarak, doğru soruyu sormak ve uygun modeli seçmek, migren gizeminin çözülmesindeki en kritik adımlardan biridir. Migraine is a debilitating neurological disorder characterized by complex mechanisms involving the trigeminovascular system, neurogenic inflammation, and central sensitization. To decipher these mechanisms and develop novel therapies, researchers employ a wide array of experimental animal models, each mimicking distinct facets of the disease. This chapter reviews this spectrum, ranging from provocative models using nitroglycerin or CGRP administration to models of cortical spreading depression (CSD) and genetic (FHM) susceptibility. Each model offers unique strengths for investigating specific aspects, such as vascular changes, pain-related behaviour, or chronification processes. However, their limitations, including species differences and translational validity, must be carefully considered. Ultimately, asking the right question and selecting the appropriate model remain pivotal steps in unraveling the enigma of migraine.
- 3 April 2026
- Published by Academician Publishing
- p. 165-170
Serebral İskemide Moleküler ve Hücresel Mekanizmalar
Serebral iskemi, beyin dokusuna giden kan akımının azalması veya kesilmesi sonucu gelişen ve yüksek mortalite ile kalıcı nörolojik sekellere yol açabilen karmaşık bir patofizyolojik süreçtir. İskemik inme, tüm inme vakalarının büyük çoğunluğunu oluşturmakta ve küresel ölçekte önemli bir sağlık yükü yaratmaktadır. Serebral iskemi/reperfüzyon (I/R) hasarı; enerji metabolizmasının çöküşü, eksitotoksisite, iyon dengesinin bozulması, oksidatif ve nitrozatif stres, nöroenflamasyon ve kan-beyin bariyeri disfonksiyonu gibi birbiriyle ilişkili mekanizmaları içeren çok basamaklı bir kaskad ile karakterizedir. Reperfüzyonun sağlanması, iskemik dokunun kurtarılması açısından kritik olmakla birlikte, aşırı reaktif oksijen türleri üretimi ve inflamatuvar yanıtın artışı nedeniyle ikincil hasarı da tetikleyebilmektedir. Bu süreçte nekrozun yanı sıra apoptoz, nekroptoz, ferroptoz, piroptoz, otofaji ve parthanatos gibi düzenlenmiş hücre ölüm yolları aktive olur. Ayrıca iskemiyi takiben gelişen anjiyogenez, nörogenez ve sinaptogenez gibi onarım ve plastisite mekanizmaları, fonksiyonel iyileşmenin temelini oluşturur. Bu bölümde, serebral iskemi ve reperfüzyon hasarının hücresel ve moleküler patofizyolojisi, zamansal ve mekânsal dinamikleriyle birlikte kapsamlı olarak ele alınmıştır. Cerebral ischemia is a complex pathophysiological condition resulting from a reduction or cessation of cerebral blood flow, leading to high mortality and long-term neurological disability. Ischemic stroke accounts for the majority of stroke cases and represents a major global health burden. The pathophysiology of cerebral ischemia/reperfusion (I/R) injury involves a multifactorial cascade that includes energy failure, excitotoxicity, ionic imbalance, oxidative and nitrosative stress, neuroinflammation, and blood–brain barrier dysfunction. Although reperfusion is essential for salvaging ischemic tissue, it can paradoxically exacerbate brain injury by triggering excessive reactive oxygen species production and inflammatory responses. In addition to necrosis, various forms of regulated cell death—such as apoptosis, necroptosis, ferroptosis, pyroptosis, autophagy, and parthanatos—contribute to neuronal loss following ischemic insult. Conversely, post-ischemic recovery processes, including angiogenesis, neurogenesis, and synaptogenesis, play crucial roles in neural repair and functional recovery. This chapter provides a comprehensive overview of the cellular and molecular mechanisms underlying cerebral ischemia and reperfusion injury, emphasizing their temporal and spatial dynamics.
- 3 April 2026
- Published by Academician Publishing
- p. 165-170
Serebral İskemide Moleküler ve Hücresel Mekanizmalar
Serebral iskemi, beyin dokusuna giden kan akımının azalması veya kesilmesi sonucu gelişen ve yüksek mortalite ile kalıcı nörolojik sekellere yol açabilen karmaşık bir patofizyolojik süreçtir. İskemik inme, tüm inme vakalarının büyük çoğunluğunu oluşturmakta ve küresel ölçekte önemli bir sağlık yükü yaratmaktadır. Serebral iskemi/reperfüzyon (I/R) hasarı; enerji metabolizmasının çöküşü, eksitotoksisite, iyon dengesinin bozulması, oksidatif ve nitrozatif stres, nöroenflamasyon ve kan-beyin bariyeri disfonksiyonu gibi birbiriyle ilişkili mekanizmaları içeren çok basamaklı bir kaskad ile karakterizedir. Reperfüzyonun sağlanması, iskemik dokunun kurtarılması açısından kritik olmakla birlikte, aşırı reaktif oksijen türleri üretimi ve inflamatuvar yanıtın artışı nedeniyle ikincil hasarı da tetikleyebilmektedir. Bu süreçte nekrozun yanı sıra apoptoz, nekroptoz, ferroptoz, piroptoz, otofaji ve parthanatos gibi düzenlenmiş hücre ölüm yolları aktive olur. Ayrıca iskemiyi takiben gelişen anjiyogenez, nörogenez ve sinaptogenez gibi onarım ve plastisite mekanizmaları, fonksiyonel iyileşmenin temelini oluşturur. Bu bölümde, serebral iskemi ve reperfüzyon hasarının hücresel ve moleküler patofizyolojisi, zamansal ve mekânsal dinamikleriyle birlikte kapsamlı olarak ele alınmıştır. Cerebral ischemia is a complex pathophysiological condition resulting from a reduction or cessation of cerebral blood flow, leading to high mortality and long-term neurological disability. Ischemic stroke accounts for the majority of stroke cases and represents a major global health burden. The pathophysiology of cerebral ischemia/reperfusion (I/R) injury involves a multifactorial cascade that includes energy failure, excitotoxicity, ionic imbalance, oxidative and nitrosative stress, neuroinflammation, and blood–brain barrier dysfunction. Although reperfusion is essential for salvaging ischemic tissue, it can paradoxically exacerbate brain injury by triggering excessive reactive oxygen species production and inflammatory responses. In addition to necrosis, various forms of regulated cell death—such as apoptosis, necroptosis, ferroptosis, pyroptosis, autophagy, and parthanatos—contribute to neuronal loss following ischemic insult. Conversely, post-ischemic recovery processes, including angiogenesis, neurogenesis, and synaptogenesis, play crucial roles in neural repair and functional recovery. This chapter provides a comprehensive overview of the cellular and molecular mechanisms underlying cerebral ischemia and reperfusion injury, emphasizing their temporal and spatial dynamics.
- Open Access
- 22 December 2025
- Published by MDPI AG in Biomedicines
- Vol. 14 (1) , 23
Neuroprotective Effects of Anodal tDCS on Oxidative Stress and Neuroinflammation in Temporal Lobe Epilepsy
Background: Epilepsy affects over 50 million people worldwide, and about 30% remain drug-resistant—underscoring the urgent need for new therapies. This study evaluated the neuroprotective effects of anodal transcranial direct current stimulation (tDCS) in PTZ-induced epilepsy at acute and chronic stages in rats. Methods: Sixty male Wistar Albino rats (12 per group) were randomly assigned to five groups: control, acute epilepsy, acute epilepsy+ tDCS, chronic epilepsy, and chronic epilepsy+ tDCS. Behavioral tests—including the open-field, novel-object recognition, and Y-maze—assessed locomotion, recognition, and spatial memory. Hippocampal tissues were analyzed for oxidative stress markers (SOD, MDA), inflammatory cytokines (IL-1β, TNF-α), histopathology, and mechanistic markers of astrocytic and nitric oxide-mediated neuronal damage (GFAP and nNOS immunohistochemistry). Results: PTZ-induced epilepsy resulted in cognitive deficits, increased oxidative stress, neuroinflammation, neuronal degeneration, and astrocytic activation. Specifically, SOD decreased, while MDA, IL-1β, and TNF-α increased; GFAP and nNOS upregulation indicated activation of astrocytes and nitric oxide-mediated neuronal damage. tDCS mitigated these effects by enhancing SOD, reducing MDA, IL-1β, and TNF-α, and modulating the NO/GFAP axis, which corresponded to decreased neuronal degeneration and vascular hyperemia. Behaviorally, tDCS improved recognition memory and partially rescued spatial memory deficits. Conclusions: Anodal tDCS exerts neuroprotective effects in acute and chronic epilepsy by modulating oxidative stress, neuroinflammation, and the astrocytic/nitric oxide pathways, supporting its potential as a non-invasive adjunct therapy for cognitive and cellular protection. Future studies should investigate its effects on hippocampal glutamatergic and GABAergic pathways, as well as calcium homeostasis.
- 22 December 2025
- Published by MDPI AG in Biomedicines
- Vol. 14 (1) , 23
Open AccessNeuroprotective Effects of Anodal tDCS on Oxidative Stress and Neuroinflammation in Temporal Lobe Epilepsy
Background: Epilepsy affects over 50 million people worldwide, and about 30% remain drug-resistant—underscoring the urgent need for new therapies. This study evaluated the neuroprotective effects of anodal transcranial direct current stimulation (tDCS) in PTZ-induced epilepsy at acute and chronic stages in rats. Methods: Sixty male Wistar Albino rats (12 per group) were randomly assigned to five groups: control, acute epilepsy, acute epilepsy+ tDCS, chronic epilepsy, and chronic epilepsy+ tDCS. Behavioral tests—including the open-field, novel-object recognition, and Y-maze—assessed locomotion, recognition, and spatial memory. Hippocampal tissues were analyzed for oxidative stress markers (SOD, MDA), inflammatory cytokines (IL-1β, TNF-α), histopathology, and mechanistic markers of astrocytic and nitric oxide-mediated neuronal damage (GFAP and nNOS immunohistochemistry). Results: PTZ-induced epilepsy resulted in cognitive deficits, increased oxidative stress, neuroinflammation, neuronal degeneration, and astrocytic activation. Specifically, SOD decreased, while MDA, IL-1β, and TNF-α increased; GFAP and nNOS upregulation indicated activation of astrocytes and nitric oxide-mediated neuronal damage. tDCS mitigated these effects by enhancing SOD, reducing MDA, IL-1β, and TNF-α, and modulating the NO/GFAP axis, which corresponded to decreased neuronal degeneration and vascular hyperemia. Behaviorally, tDCS improved recognition memory and partially rescued spatial memory deficits. Conclusions: Anodal tDCS exerts neuroprotective effects in acute and chronic epilepsy by modulating oxidative stress, neuroinflammation, and the astrocytic/nitric oxide pathways, supporting its potential as a non-invasive adjunct therapy for cognitive and cellular protection. Future studies should investigate its effects on hippocampal glutamatergic and GABAergic pathways, as well as calcium homeostasis.